EPISODE · May 4, 2026 · 36 MIN
Office Hours #881 | Made From Mistakes | Executive Leadership in Times of Change: Biotech, Transformation & AI Evolution
from Office Hours with David Meltzer
Dr. Jeremy Levin is a prominent leader in biotechnology and global healthcare, known for blending innovation with accountability across a career that spans medicine, science, and executive leadership. He has held top roles at major organizations, including serving as CEO of Teva—where the company supplied a significant share of U.S. generic prescriptions—and leadership positions at Bristol Myers Squibb and Novartis. Currently the Executive Chair of Ovid Therapeutics and a board member of BIO, Levin brings a unique, multidimensional perspective shaped by experiences ranging from clinical medicine and scientific breakthroughs in immunotherapy to wartime leadership and his early life escaping apartheid-era South Africa. His upcoming book, Biotech in the Balance, offers an insider’s view on the challenges facing the industry and what must change to ensure reliable access to life-saving medicines. John Polo is a keynote speaker, author, and international coach whose work centers on resilience, healing, and personal transformation. After the devastating loss of his wife to cancer in 2016, he faced profound grief and instability but ultimately rebuilt his life with a renewed sense of purpose. Today, he uses his experiences to help others navigate pain, self-doubt, and emotional struggles, sharing insights through books, podcasts, coaching, and speaking engagements. With more than 5,000 coaching sessions and features on major media platforms, John’s message emphasizes kindness, self-worth, and the power of rebuilding—both personally and emotionally. Dr. Fernando De La Peña Llaca is a three-time NASA award-winning innovator and CEO of Aexa Aerospace and Aexa Tech, recognized for advancing AI and communication technologies. He led the first-ever two-way holographic teleportation between Earth and the International Space Station, demonstrating groundbreaking possibilities for remote human interaction. A successful entrepreneur with multiple company exits, he is now focused on scaling HoloConnect AI, a platform designed to bring immersive, device-agnostic communication to industries like healthcare and government. With growing national recognition, including potential inclusion in the White House’s 250th Anniversary showcase, his work is redefining how AI and holographic technology can transform real-world applications.See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
What this episode covers
Dr. Jeremy Levin is a prominent leader in biotechnology and global healthcare, known for blending innovation with accountability across a career that spans medicine, science, and executive leadership. He has held top roles at major organizations, including serving as CEO of Teva—where the company supplied a significant share of U.S. generic prescriptions—and leadership positions at Bristol Myers Squibb and Novartis. Currently the Executive Chair of Ovid Therapeutics and a board member of BIO, Levin brings a unique, multidimensional perspective shaped by experiences ranging from clinical medicine and scientific breakthroughs in immunotherapy to wartime leadership and his early life escaping apartheid-era South Africa. His upcoming book, Biotech in the Balance, offers an insider’s view on the challenges facing the industry and what must change to ensure reliable access to life-saving medicines. John Polo is a keynote speaker, author, and international coach whose work centers on resilience, healing, and personal transformation. After the devastating loss of his wife to cancer in 2016, he faced profound grief and instability but ultimately rebuilt his life with a renewed sense of purpose. Today, he uses his experiences to help others navigate pain, self-doubt, and emotional struggles, sharing insights through books, podcasts, coaching, and speaking engagements. With more than 5,000 coaching sessions and features on major media platforms, John’s message emphasizes kindness, self-worth, and the power of rebuilding—both personally and emotionally. Dr. Fernando De La Peña Llaca is a three-time NASA award-winning innovator and CEO of Aexa Aerospace and Aexa Tech, recognized for advancing AI and communication technologies. He led the first-ever two-way holographic teleportation between Earth and the International Space Station, demonstrating groundbreaking possibilities for remote human interaction. A successful entrepreneur with multiple company exits, he is now focused on scaling HoloConnect AI, a platform designed to bring immersive, device-agnostic communication to industries like healthcare and government. With growing national recognition, including potential inclusion in the White House’s 250th Anniversary showcase, his work is redefining how AI and holographic technology can transform real-world applications. See Privacy Policy at https://art19.com/privacy and California Privacy Notice at https://art19.com/privacy#do-not-sell-my-info.
NOW PLAYING
Office Hours #881 | Made From Mistakes | Executive Leadership in Times of Change: Biotech, Transformation & AI Evolution
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.